Skip to main content

Advances in Allergic Skin Diseases: From Immunopathogenesis to Precision Management

  • 629

    Total views and downloads

About this Research Topic

Submission deadlines

  1. Manuscript Submission Deadline 8 March 2027

  2. This Research Topic is currently accepting articles

Background

Allergic skin diseases, including atopic dermatitis, chronic urticaria, angioedema, prurigo nodularis, allergic contact dermatitis, and other related disorders, represent a major global health challenge with complex and multifactorial origins. Over the past decade, deepened insights into immunopathogenesis have reshaped our understanding of these diseases, particularly through discoveries in epithelial barrier dysfunction, type 2 inflammation, neuroimmune interactions, autoimmunity, and microbiome dysbiosis. Studies have identified critical immune pathways and biomolecular networks underlying disease heterogeneity, yet significant variability persists across patients in clinical presentation, immune profiles, and response to therapy. While biologics and small-molecule inhibitors have revolutionized treatment paradigms, there remains an urgent need to refine patient stratification frameworks through integration of biomarkers and molecular signatures. Current research continues to seek effective translation of these advances into long-term disease control and personalized management strategies.

This Research Topic aims to provide a state-of-the-art overview of current progress and emerging directions in allergic skin diseases, with a particular emphasis on the intersection between immunopathogenesis and precision management. It seeks to show key mechanisms underlying disease heterogeneity, explore novel biomarkers for disease classification and treatment response, and evaluate the efficacy of targeted therapeutic interventions. Contributions are encouraged to address critical questions related to disease endotyping, optimization of precision-based treatment regimens, and the integration of translational research findings into clinical care. By bridging fundamental immunology with real-world dermatological practice, this Research Topic strives to foster dialogue between basic scientists, clinicians, and translational researchers in shaping next-generation management strategies.

To gather further insights into the evolving landscape of allergic skin diseases and precision medicine, submissions are invited that examine diverse biological, technological, and clinical perspectives in this field. We welcome articles addressing, but not limited to, the following themes:
o Immunopathogenesis of allergic skin diseases
o Skin barrier dysfunction and epithelial immune responses
o Type 2 inflammation and beyond: emerging immune pathways
o Autoimmunity and autoallergy in chronic spontaneous urticaria
o Neuroimmune regulation of itch and inflammation
o Microbiome-host interactions and their therapeutic potential
o Disease endotypes and molecular classification
o Biomarkers for diagnosis, severity assessment, prognosis, and treatment response
o Biologics and targeted therapies, JAK inhibitors and other small-molecule therapies
o Integrative and precision management using treat-to-target approaches
o Digital health tools, remote monitoring, and patient-reported outcomes
o Pediatric allergic dermatoses and early intervention strategies
o Real-world evidence, comorbidities, and multidisciplinary care models
o Future directions in translational and clinical research for personalized dermatology

Research Topic Research topic image

Article types and fees

This Research Topic accepts the following article types, unless otherwise specified in the Research Topic description:

  • Brief Research Report
  • Case Report
  • Clinical Trial
  • Editorial
  • FAIR² Data
  • General Commentary
  • Hypothesis and Theory
  • Methods
  • Mini Review

Articles that are accepted for publication by our external editors following rigorous peer review incur a publishing fee charged to Authors, institutions, or funders.

Keywords: Allergic skin diseases, immunopathogenesis, biomarkers, targeted therapy, precision medicine

Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Topic editors

Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.

Impact

  • 629Topic views
View impact